.beta.-Adrenoceptor stimulant properties of amidoalkylamino-substituted 1-aryl-2-ethanols and 1-(aryloxy)-2-propanols
摘要:
Parallel series of 2-[(2-amidoethyl)amino]-1-arylethanols and 1-[(2-amidoethyl)amino]-3-(aryloxy)-2-propanols have been prepared, and the compounds were tested as beta-adrenoceptor stimulants on the heart and circulation of the dog. The corresponding 2-(alkylamino)-1-arylethanols and 3-(alkylamino)-2-propanols have been tested for comparison and the structure-activity relationships (SAR) examined. The arylethanols are potent full agonists, showing selectivity for the heart relative to blood vessels, while the (aryloxy)propanols are even more cardioselective and are partial agonists. Within a narrow series of 1-[(amidoethyl)amino]-3-(4-hydroxyphenoxy)-2-propanols, careful examination of the SAR of the amide group showed that great variation in cardioselectivity and degree of agonism may be produce. From this study ICI 118587, N-[20[[2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]-4-morpholinecarboxamide, was selected for its high cardioselectivity and 50% agonist properties. This compound in under clinical evaluation as a cardiac stimulant.
[EN] FUSED TRICYCLIC PYRAZOLE DERIVATIVES USEFUL FOR MODULATING FARNESOID X RECEPTORS<br/>[FR] DÉRIVÉS DE PYRAZOLE TRICYCLIQUES FUSIONNÉS UTILES POUR MODULER DES RÉCEPTEURS FARNÉSOÏDES X
申请人:NOVARTIS AG
公开号:WO2016174616A1
公开(公告)日:2016-11-03
The present invention relates to compounds of Formula I, a stereoisomer, enantiomer, a pharmaceutically acceptable salt or an amino acid conjugate thereof; wherein variables are as defined herein; and their pharmaceutical compositions, which are useful as modulators of the activity of Farnesoid X receptors (FXR).
Fused tricyclic pyrazole derivatives useful for farnesoid X receptors
申请人:NOVARTIS AG
公开号:US10351576B2
公开(公告)日:2019-07-16
The present invention relates to compounds of Formula I,
a stereoisomer, enantiomer, a pharmaceutically acceptable salt or an amino acid conjugate thereof; wherein variables are as defined herein; and their pharmaceutical compositions, which are useful as modulators of the activity of Farnesoid X receptors (FXR).
本发明涉及式 I 的化合物、
其立体异构体、对映体、药学上可接受的盐或氨基酸共轭物;其中变量如本文所定义;以及它们的药物组合物,可用作法尼类固醇 X 受体(FXR)活性的调节剂。
CH605666
申请人:——
公开号:——
公开(公告)日:——
FR2233991
申请人:——
公开号:——
公开(公告)日:——
BARLOW J. J.; MAIN B. G.; SNOW H. M., J. MED. CHEM., 1981, 24, NO 3, 315-322